Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lorenzo Trippa, Ph.D.

Co-Author

This page shows the publications co-authored by Lorenzo Trippa and Jonathan Schoenfeld.
Connection Strength

2.532
  1. Reply to "Keynote 48: Is it really for everyone?" Oral Oncol. 2021 04; 115:105108.
    View in: PubMed
    Score: 0.934
  2. Keynote 48: Is it really for everyone? Oral Oncol. 2020 06; 105:104762.
    View in: PubMed
    Score: 0.897
  3. The effects of releasing early results from ongoing clinical trials. Nat Commun. 2021 02 05; 12(1):801.
    View in: PubMed
    Score: 0.236
  4. Lessons Learned from Deescalation Trials in Favorable Risk HPV-Associated Squamous Cell Head and Neck Cancer-A Perspective on Future Trial Designs. Clin Cancer Res. 2019 12 15; 25(24):7281-7286.
    View in: PubMed
    Score: 0.215
  5. Hazards of Hazard Ratios - Deviations from Model Assumptions in Immunotherapy. N Engl J Med. 2018 03 22; 378(12):1158-1159.
    View in: PubMed
    Score: 0.194
  6. A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer. Clin Breast Cancer. 2020 06; 20(3):238-245.
    View in: PubMed
    Score: 0.055
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.